The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study

The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study

Authors

  • Morteza Safi Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mohammad Ali Mehrabi Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Saeed Alipour Parsa Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Isa Khaheshi Cardiovascular Research Center, Modarres hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mohammadreza Naderian Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.

Keywords:

Fractional Flow Reserve, Myocardial, Coronary Vessels, Cost-Benefit Analysis, Percutaneous Coronary Intervention, Coronary Artery Bypass

Abstract

Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study was conducted on140 consecutive patients with 219 diseased arteries who underwent coronary angiography and suffered intermediate coronary lesions. Results: Of 18 patients who candidate for CABG before FFR, only one patient underwent CABG after determining FFR (P-value<0.05), while 15 patients were scheduled for PCI and 2 patients for medical treatment. Of 122 patients who candidate for PCI, 59 were programmed to underwent PCI after FFR determination(P-value<0.05), while the strategy in 63 patients (47 with one-vessel disease, 15 with two vessel diseases, and 1 with three vessel diseases) was modified to medical treatment. Considering strategy modifying from PCI to medical treatment, 101 stents were saved (P-value<0.05). Also, in change of strategy from CABG to PCI, spending has decreased as much as 77.3% (P-value<0.05). Furthermore, the change of treatment approach from PCI on much number of coronary vessels to PCI on less number of coronary lesions led to saving of 52.2% of costs(P-value<0.05). Conclusions: In patients with an intermediate coronary lesion, measuring FFR to guide the decision to determine treatment strategy may lead to significant cost savings.

Downloads

Published

08-10-2018

Issue

Section

ORIGINAL ARTICLES

How to Cite

1.
Safi M, Mehrabi MA, Alipour Parsa S, Khaheshi I, Naderian M. The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study. Acta Biomed [Internet]. 2018 Oct. 8 [cited 2024 Jul. 18];89(3):378-81. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/5605